How should we discuss genetic testing with women newly diagnosed with breast cancer? Design and implementation of a randomized controlled trial of two models of delivering education about treatment-focused genetic testing to younger women newly diagnosed with breast cancer

<p>Abstract</p> <p>Background</p> <p>Germline <it>BRCA1</it> and <it>BRCA2</it> mutation testing offered shortly after a breast cancer diagnosis to inform women’s treatment choices - treatment-focused genetic testing ‘TFGT’ - has entered clinical practice in specialist centers and is likely to be so...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Watts Kaaren J, Meiser Bettina, Mitchell Gillian, Kirk Judy, Saunders Christobel, Peate Michelle, Duffy Jessica, Kelly Patrick J, Gleeson Margaret, Barlow-Stewart Kristine, Rahman Belinda, Friedlander Michael, Tucker Kathy
Format:	Artigo
Język:	Inglês
Wydane:	BMC 2012-07-01
Seria:	BMC Cancer
Hasła przedmiotowe:	Breast cancer Genetic testing <it>BRCA1</it> <it>BRCA</it>2 Treatment Clinical practice
Dostęp online:	http://www.biomedcentral.com/1471-2407/12/320
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!